Letaplimab (Anti-CD47) | CD markers antibody | Read Reviews & Product Use Citations

Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.

References
[1] Miao M, et al. Blood (2022) 140 (Supplement 1): 4045–4046.

References

[1] Miao M, et al. Blood (2022) 140 (Supplement 1): 4045–4046.

Product Details

CAS No.	2283356-07-8
Molecular Weight	142.88
Isotype	Human IgG4SP
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field